Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Ameliorates the Cytokine Milieu and Endothelial Injury Following Myeloablative Conditioning
Author(s) -
Gary Simmons,
Roy Sabo,
Erika J. Martin,
Donald F. Brophy,
Maja Silobrčić Radić,
Bernard Fisher,
Ramesh Natarajan,
Dayanjan S. Wijesinghe,
Alexandra Gol-Chambers,
C. E. Hall,
May Aziz,
Kelly G. Hawks,
Ali Jafri,
Robyn J. Bernard,
Harold M. Chung,
William Clark,
John M. McCarty,
Catherine Roberts,
Alpha A. Fowler,
Amir A. Toor
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.667
Subject(s) - medicine , busulfan , ascorbic acid , fludarabine , gastroenterology , total body irradiation , sepsis , melphalan , cyclophosphamide , mucositis , bone marrow , transplantation , hematopoietic stem cell transplantation , surgery , toxicity , chemotherapy , chemistry , food science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom